Company / Return on Assets (ROA)
Ernexa Therapeutics Inc. Return on Assets (ROA) History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-763.4%
FY2025
5-year range
-763.4% / -1.8%
FY2021-FY2025
Trend
-85.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -763.4% in FY2025 to -1.8% in FY2019.
Based on SEC 10-K filings.
-763.4% in FY2025 with a 10-year CAGR of -732.8%.
Declined from -50.0% to -763.4% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -708.8pp
- 10-Year Change
- -732.8pp
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 85.6% year-over-year.
- Peak return on assets (roa) was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -763.4% | -85.6% |
| FY2024 | -411.2% | -722.0% |
| FY2023 | -50.0% | +8.5% |
| FY2020 | -54.7% | -2886.9% |
| FY2019 | -1.8% | +74.8% |
| FY2018 | -7.2% | +58.9% |
| FY2017 | -17.6% | +59.2% |
| FY2016 | -43.3% | -41.2% |
| FY2015 | -30.7% | -548.2% |
| FY2014 | -4.7% | +26.6% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026